Airway Progenitor Dysfunction During Early COPD
Primary Objective
Do you currently smoke? Would you like to know if you are one of the 4 in 10 people who may develop COPD someday?
Description
You may be eligible for the APD Research Study, which is designed to identify objective measurements (known as biomarkers) of COPD at its earliest stages. These biomarkers can help identify individuals most susceptible to COPD and explore new treatments to address the underlying causes of the disease. What is involved if I participate? Participants may have annual study visits over 2-4 years. Study visits include lung function assessments, two bronchoscopies, CT scans, and the collection of biological samples. Study procedures are provided at no charge. Those who take part will receive compensation for their participation. If you are interested in participating or want to learn more, contact the Vandivier Research Team Call: 303-724-6067 E-mail: apdstudy1@cuanschutz.edu
Details
Locations
Boulder Health Center
Broomfield Hospital
Cherry Creek Medical Center
CTRC Inpatient
Highlands Ranch Hospital
Lone Tree Medical Center
Longs Peak Hospital
Outpatient CTRC
UCHealth Central Park Medical Center
UCHealth Internal Medical Clinic - Lowry
UCHealth Northfield Medical Center
UCHealth Steadman Hawkins Clinic - Denver (Inverness)
University of Colorado Hospital
Principal Investigator
Richard Vandivier
Study ID
Protocol Number: 23-1215
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers